A business in context
KNSA research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-04-28 | Patel Sanj K | M · Exercise / conversion | Share Option | 431904.0 | 0.0 |
| 2026-04-28 | Quart Barry D | M · Exercise / conversion | Class A Ordinary Share | 13099.0 | 14.33 |
| 2026-04-28 | Quart Barry D | S · Sale | Class A Ordinary Share | 13099.0 | 50.1 |
| 2026-04-28 | Quart Barry D | M · Exercise / conversion | Share Option | 13099.0 | 0.0 |
| 2026-04-09 | Moat Ross | S · Sale | Class A Ordinary Share | 1703.0 | 46.69 |
| 2026-04-09 | Megna Michael R | S · Sale | Class A Ordinary Share | 6625.0 | 46.69 |
| 2026-04-07 | Tessari Eben | F · Tax / exercise payment | Class A Ordinary Share | 846.0 | 48.94 |
| 2026-04-07 | Tessari Eben | M · Exercise / conversion | Class A Ordinary Share | 2726.0 | — |
| 2026-04-07 | Tessari Eben | M · Exercise / conversion | Restricted Share Unit | 2726.0 | 0.0 |
| 2026-04-07 | Moat Ross | F · Tax / exercise payment | Class A Ordinary Share | 774.0 | 48.94 |
| 2026-04-07 | Moat Ross | M · Exercise / conversion | Class A Ordinary Share | 2477.0 | — |
| 2026-04-07 | Moat Ross | M · Exercise / conversion | Restricted Share Unit | 2477.0 | 0.0 |
| 2026-04-07 | Ragosa Mark | M · Exercise / conversion | Class A Ordinary Share | 2694.0 | — |
| 2026-04-07 | Ragosa Mark | F · Tax / exercise payment | Class A Ordinary Share | 1303.0 | 48.94 |
| 2026-04-07 | Ragosa Mark | M · Exercise / conversion | Restricted Share Unit | 2694.0 | 0.0 |
| 2026-04-07 | Paolini John F. | M · Exercise / conversion | Class A Ordinary Share | 2497.0 | — |
| 2026-04-07 | Paolini John F. | F · Tax / exercise payment | Class A Ordinary Share | 1208.0 | 48.94 |
| 2026-04-07 | Paolini John F. | M · Exercise / conversion | Restricted Share Unit | 2497.0 | 0.0 |
| 2026-04-07 | Patel Sanj K | F · Tax / exercise payment | Class A Ordinary Share | 4831.0 | 48.94 |
| 2026-04-07 | Patel Sanj K | M · Exercise / conversion | Class A Ordinary Share | 9991.0 | — |
| 2026-04-07 | Patel Sanj K | M · Exercise / conversion | Restricted Share Unit | 9991.0 | 0.0 |
| 2026-04-07 | Megna Michael R | M · Exercise / conversion | Class A Ordinary Share | 3932.0 | 1.0 |
| 2026-04-07 | Megna Michael R | F · Tax / exercise payment | Class A Ordinary Share | 1666.0 | 48.94 |
| 2026-04-07 | Megna Michael R | M · Exercise / conversion | Restricted Share Unit | 3932.0 | 0.0 |
| 2026-04-06 | Moat Ross | S · Sale | Class A Ordinary Share | 2367.0 | 48.58 |
| 2026-04-06 | Patel Sanj K | S · Sale | Class A Ordinary Share | 7278.0 | 50.01 |
| 2026-04-06 | Patel Sanj K | M · Exercise / conversion | Class A Ordinary Share | 7278.0 | 10.36 |
| 2026-04-06 | Patel Sanj K | M · Exercise / conversion | Share Option | 7278.0 | 0.0 |
| 2026-04-06 | Quart Barry D | M · Exercise / conversion | Class A Ordinary Share | 6901.0 | 14.33 |
| 2026-04-06 | Quart Barry D | S · Sale | Class A Ordinary Share | 6901.0 | 50.0 |
| 2026-04-06 | Quart Barry D | M · Exercise / conversion | Share Option | 6901.0 | 0.0 |
| 2026-04-01 | Tessari Eben | M · Exercise / conversion | Class A Ordinary Share | 5975.0 | — |
| 2026-04-01 | Tessari Eben | F · Tax / exercise payment | Class A Ordinary Share | 1756.0 | 48.13 |
| 2026-04-01 | Tessari Eben | A · Grant / award | Restricted Share Unit | 8300.0 | 0.0 |
| 2026-04-01 | Tessari Eben | A · Grant / award | Performance Share Unit | 16600.0 | 0.0 |
| 2026-04-01 | Tessari Eben | M · Exercise / conversion | Restricted Share Unit | 1745.0 | 0.0 |
| 2026-04-01 | Tessari Eben | M · Exercise / conversion | Restricted Share Unit | 2457.0 | 0.0 |
| 2026-04-01 | Tessari Eben | A · Grant / award | Share Option | 33200.0 | 0.0 |
| 2026-04-01 | Tessari Eben | M · Exercise / conversion | Restricted Share Unit | 1773.0 | 0.0 |
| 2026-04-01 | Moat Ross | M · Exercise / conversion | Class A Ordinary Share | 5808.0 | — |
| 2026-04-01 | Moat Ross | F · Tax / exercise payment | Class A Ordinary Share | 1706.0 | 48.13 |
| 2026-04-01 | Moat Ross | A · Grant / award | Share Option | 36950.0 | 0.0 |
| 2026-04-01 | Moat Ross | A · Grant / award | Restricted Share Unit | 9250.0 | 0.0 |
| 2026-04-01 | Moat Ross | A · Grant / award | Performance Share Unit | 18500.0 | 0.0 |
| 2026-04-01 | Moat Ross | M · Exercise / conversion | Restricted Share Unit | 1611.0 | 0.0 |
| 2026-04-01 | Moat Ross | M · Exercise / conversion | Restricted Share Unit | 2457.0 | 0.0 |
| 2026-04-01 | Moat Ross | M · Exercise / conversion | Restricted Share Unit | 1740.0 | 0.0 |
| 2026-04-01 | Ragosa Mark | F · Tax / exercise payment | Class A Ordinary Share | 2510.0 | 48.13 |
| 2026-04-01 | Ragosa Mark | M · Exercise / conversion | Class A Ordinary Share | 5187.0 | — |
| 2026-04-01 | Ragosa Mark | A · Grant / award | Restricted Share Unit | 7800.0 | 0.0 |
Identity & relationships
SEC issuer · 0001730430Kiniksa Pharmaceuticals International, plc
Search names and former names
- Kiniksa Pharmaceuticals, Ltd. · former SEC name · 2018-02-27 to 2024-06-28
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $423.24M | $450.52M |
| 2023-12-31 | $270.26M | $296.15M |
| 2022-12-31 | $220.18M | $251.18M |
| 2021-12-31 | $38.54M | $47.49M |